Severe Hepatotoxicity of Telithromycin

Joseph S. Bertino

doi:10.7326/0003-4819-145-6-200609190-00015

Letters |19 September 2006

Severe Hepatotoxicity of Telithromycin

Joseph S. Bertino, PharmD

Article, Author, and Disclosure Information

TO THE EDITOR:

Although Clay and colleagues' article on possible telithromycin-induced hepatic toxicity was of interest (1), some clarifications are needed. In case 1, the authors report that the patient presented with a 4-day history of dark urine, jaundice, and malaise that began on the second day of telithromycin therapy. However, the authors then state that the drug was “withdrawn after 3 days of therapy” when laboratory results (presumably obtained at the time of patient presentation) were obtained. The time course is confusing as reported.

In case 3, the authors note that “levels of acetaminophen, salicylate, and ethylene glycol were subsequently found to be normal.” Generally, there are no “normal” concentrations of acetaminophen and salicylate (unless the patient was taking these medications, in which case “normal ranges” may be appropriate). However, the case report did not suggest that the patient was taking either of these medications. Although suggestions about treatment of ethylene glycol ingestion recommend monitoring serum concentrations (along with a host of other things), ethylene glycol is generally not found in the body unless there has been an exposure (deliberate or accidental) (2). This also needs clarification for readers.

FULL TEXT

PDF

Not Available

2006 American College of Physicians

Letters |19 September 2006

Severe Hepatotoxicity of Telithromycin

See Also

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

Letters |19 September 2006

Severe Hepatotoxicity of Telithromycin

See Also

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

You need a subscription to this content to use this feature.